DOI: 10.2337/db05-1355 © 2006 by the American Diabetes Association C16:0 Sulfatide Inhibits Insulin Secretion in Rat ß-Cells by Reducing the Sensitivity of KATP Channels to ATP Inhibition
1 Bartholin Instituttet, Rigshospitalet, Copenhagen, Denmark Address correspondence and reprint requests to Dr. Karsten Buschard, Bartholin Instituttet, Rigshospitalet, 2100 Copenhagen, Denmark. E-mail: buschard{at}dadlnet.dk
Abbreviations:
[Ca2+]i, cytoplasmic free Ca2+ concentration; ELISA, enzyme-linked immunosorbent assay; GalCer, galactosyl ceramide; HPTLC, high-performance thin-layer chromatography; KATP channel, ATP-sensitive K+ channel; KRBH, Krebs-Ringer bicarbonate HEPES buffer; PIP, phosphatidylinositol phosphate; SulfLacCer, sulfated lactosyl ceramide; TLC, thin-layer chromatography
Sulfatide (3'-sulfo-ß-galactosyl ceramide) is a glycosphingolipid present in mammalians in various fatty acid isoforms of which the saturated 16 carbon-atom length (C16:0) is more abundant in pancreatic islets than in neural tissue, where long-chain sulfatide isoforms dominate. We previously reported that sulfatide isolated from pig brain inhibits glucose-induced insulin secretion by activation of ATP-sensitive K+ channels (KATP channels). Here, we show that C16:0 sulfatide is the active isoform. It inhibits glucose-stimulated insulin secretion by reducing the sensitivity of the KATP channels to ATP. (The half-maximal inhibitory concentration is 10.3 and 36.7 µmol/l in the absence and presence of C16:0 sulfatide, respectively.) C16:0 sulfatide increased whole-cell KATP currents at intermediate glucose levels and reduced the ability of glucose to induce membrane depolarization, reduced electrical activity, and increased the cytoplasmic free Ca2+ concentration. Recordings of cell capacitance revealed that C16:0 sulfatide increased Ca2+-induced exocytosis by 215%. This correlated with a stimulation of insulin secretion by C16:0 sulfatide in intact rat islets exposed to diazoxide and high K+. C24:0 sulfatide or the sulfatide precursor, ß-galactosyl ceramide, did not affect any of the measured parameters. C16:0 sulfatide did not modulate glucagon secretion from intact rat islets. In ßTC3 cells, sulfatide was expressed (mean [±SD] 0.30 ± 0.04 pmol/µg protein), and C16:0 sulfatide was found to be the dominant isoform. No expression of sulfatide was detected in
|
|
|
||||||||||||||||||||||||||